Researchers at Penn Medicine conducted a pilot randomized controlled trial to test the hypothesis that an e-triage ...

BEIJING (Kyodo) -- Chinese Commerce Minister Wang Wentao on Tuesday urged Japanese business leaders to "join hands" with ...

What is a menopause health assessment? And how will it improve the health care women receive during this stage in their lives ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

The approvals were based on positive results from EV-302, in which Padcev plus Keytruda resulted in statistically significant ...

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

US FDA approves expanded label for Astellas’ Izervay for the treatment of geographic atrophy: Tokyo Friday, February 14, 2025, 09:00 Hrs [IST] Astellas Pharma Inc., a global lif ...

HeartcoR Solutions, a leading ECG core lab that conducts cardiac safety studies for the pharmaceutical, medical device, and ...

The US Food and Drug Administration (FDA) approved expanding the prescribing information for Japanese drugmaker Astellas ...

The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...